A study to assess the effect of rinsing of new liver graft during the liver transplantaion.

Graft Rinse prior to reperfusion In LDLT, an RCT : GRIT Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068527

Enrollment

Registered

2024-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Heta Starch 500 ml: The right hepatic vein (RHV) anastomosis will be completed (apart from the last knot) using continuous Proline 5/0 sutures. After completion of the portal vein (PV)

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients undergoing live donor liver transplantation

Exclusion criteria

Exclusion criteria: Patient refusing to consent Pediatric Transplants Patients refusing to consent trial

Design outcomes

Primary

Measure	Time frame
incidence of postreperfusion syndrome between control group and intervention groupTimepoint: at 5 minutes post-reperfusion,	—

Secondary

Measure	Time frame
lengths of intensive care stay & hospital stay, Early allograft Dysfunction, Primary Non function of the Graft, early postop- erative complications , & patient survival.Timepoint: in 30 days; and 3 month -survival assessment	—

Countries

India

Contacts

Public ContactSudhindran S

Amrita Institute of Medical Sciences and Research Centre

sudhisalini@icloud.com9388623851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026